Introduction
============

This is the 2016 Annual Report of University of Kansas Health System Poison Control Center (PCC). The PCC is a 24-hour 365 day/year health care information resource serving the state of Kansas. It was founded in 1982 and is certified with the American Association of Poison Control Centers (AAPCC). Currently, there are 55 certified poison control centers in the United States. The PCC is staffed by 10 certified specialists in poison information who are either critical care trained nurses or doctors of pharmacy. There is 24-hour back up provided by board certified medical toxicologists. The PCC receives calls from the public, law enforcement, health care professionals, and public health agencies. Encounters may involve an exposed animal or human (Exposure Call) or a request for information with no known exposure (Information Call). The PCC follows all cases to make management recommendations, monitor case progress, and document medical outcome. This information is recorded electronically in the Toxicall® data management system and uploaded in near real-time to the National Poison Data System (NPDS). NPDS is the data warehouse for all of the nation's poison control centers.[@b1-kjm-11-2-24] The NPDS utilizes a products database that contains over 427,000 products to classify exposures. The database is maintained and updated continuously by data analysts at the Micromedex Poisindex® System.[@b1-kjm-11-2-24] The average time to upload data for all PCs is 9.52 minutes, creating a real-time national exposure database and surveillance system.[@b1-kjm-11-2-24] The PCC has the ability to share NPDS real time surveillance with state and local health departments and other regulatory agencies. What follows is analysis and summary of all encounters reported to the PCC from January 1, 2016 to December 31, 2016.

Methods
=======

All PCC encounters recorded electronically in the Toxicall® data management system from January 1, 2016 to December 31, 2016 were analyzed. Cases were first classified as either an exposure or suspected exposure (Human Exposure, Animal Exposure, Non-Exposure Confirmed Cases) or a request for information with no reported exposure (Information Call). Data extracted includes caller location, age, weight, gender, exposure substance, number of follow-up calls, and nature of exposure (i.e., unintentional, recreational, or intentional). Additional data collected included exposure scenario, route of exposure (oral, dermal, parenteral), interventions, medical outcome (no effect, minor, moderate, severe, or death), disposition (admitted to noncritical care unit, admitted to critical care unit, admitted to psychiatry unit, lost to follow-up, or treated and released) and location of care (non-health care facility or health care facility). For this analysis, a pediatric case was defined as any patient 19 years of age or less. This is consistent with NPDS methodology. For medical outcome, the following definitions were used: minor - minimally bothersome symptoms, moderate - more pronounced symptoms, usually requiring treatment, and major life threatening signs and symptoms.

Data were analyzed using Microsoft Excel (Microsoft Corp, Redmond, WA).

Results
=======

The PCC logged 21,965 total calls in 2016, including 20,713 human exposure cases, 87 non-exposure confirmed cases, 112 animal exposure cases, and 1,053 information calls. For information calls, drug information (n = 308) was most common reason for calling. [Table 1](#t1-kjm-11-2-24){ref-type="table"} further describes the encounter types. The PCC made 32,137 follow-up calls in 2016. Follow-up calls were done in 60.9% of human exposure cases. One follow-up call was made in 29.5% of human exposure cases and multiple follow-up calls (range 2 -- 44) were made in 31.3% of cases. In human exposure calls for which follow-up calls were made, an average of 2.54 follow-up calls per case were performed.

The PCC received calls from all 105 counties in Kansas. The county with the most number of calls was Sedgwick County with 3,358. In addition, calls were received from 47 states, the District of Columbia, and 12 calls were from foreign countries, including Turkey and Uganda.

The majority of human exposure cases (50.4%, n = 10,174) were female. A male predominance was found among encounters involving children younger than 13 years of age, but this gender distribution was reversed in teenagers and adults, with females comprising the majority of reported exposures. Approximately 67% (n = 13,903) of human exposures involved a child (defined as age 19 years or less). [Table 2](#t2-kjm-11-2-24){ref-type="table"} illustrates distribution of human exposures by age and gender. [Figure 1](#f1-kjm-11-2-24){ref-type="fig"} demonstrates that patients 1 year of age were the most common age group involved in encounters reported to the PCC. For adults, the age group of 20 -- 29 years old was encountered most commonly ([Figure 2](#f2-kjm-11-2-24){ref-type="fig"}). Seventy-five (75) exposures occurred in pregnant women (0.4% of all human exposures). Of these exposures, 26.7% occurred in the first trimester, 42.7% occurred in the second trimester, and 28.0% occurred in the third trimester. Most of these exposures (78.7%) were unintentional exposures and 12.0% were intentional exposures. There were no reported deaths to PCC in pregnant women in 2016.

For human exposures, 72.3% (n = 14,964) of calls originated from a residence (own or other), while 94.0% (n = 19,476) of these exposures actually occurred at a residence (own or other). Calls from a health care facility accounted for 21.7% (n = 4,500) of human exposure encounters. [Table 3](#t3-kjm-11-2-24){ref-type="table"} further details the origin of human exposure calls and where the exposure took place.

The majority of human exposures (n = 18,233) were acute cases (exposures occurring over eight hours or less). Chronic exposures (exposures occurring \> 8 hours) accounted for 1.6% (327) of all human exposures reported. Acute on chronic exposures (single exposure that was preceded by a chronic exposure \> 8 hours) totaled 2063 (9.96%). Ingestion was the most common route of exposure documented (86.3%, n = 17,882) in all cases ([Table 4](#t4-kjm-11-2-24){ref-type="table"}).

The most common reported substance in those less than 5 years of age was cosmetics/personal care products (n = 1,362) followed closely by household cleaning products (n = 1,301). For adult (\> 20 years of age) encounters, sedatives/hypnotics/antipsychotics (n = 1,130) and analgesics (n = 1,103) were the most frequently involved substances. Among all encounters, analgesics (n = 2,813, 11%) were the most frequently encountered substance category. [Table 5](#t5-kjm-11-2-24){ref-type="table"} lists most frequently encountered substance categories for pediatric encounters and [Table 6](#t6-kjm-11-2-24){ref-type="table"} lists those for adult encounters. \[A summary log for all exposures categorized by category and sub-category of substance is available with the manuscript on the website: [kjm.kumc.edu](http://kjm.kumc.edu)\].

There were a total of 399 plant exposures reported to the PCC. The most common plant exposure encountered was to pokeweed (*Phytolacca Americana*; n = 48). [Table 7](#t7-kjm-11-2-24){ref-type="table"} lists the top 5 most encountered plants.

Unintentional exposures were the most common reason for exposures (81.3%, n = 16,836) while intentional exposures accounted for 16.3% (n = 3,377) of exposures. [Table 8](#t8-kjm-11-2-24){ref-type="table"} lists reasons for human exposures. A majority of unintentional exposures (n = 10,897) occurred in the less than 5 years old age group. Up to age 12, 98.9% (n = 12,171) of ingestions were unintentional. However, in the 13 -- 19 year-old group, intentional exposure was most common (63.1%, n = 1,087). In total, suspected suicide attempts accounted for 11.7% (n = 2,415) of human encounters. When a therapeutic error was the reason for exposure, a double dose was the most common scenario (n = 775).

Most encounters (71.1%, n = 14,732) were managed in a non-health care facility (i.e., a residence). Of the 5,747 encounters managed at a health care facility, 42% (n = 2419) were admitted. [Table 9](#t9-kjm-11-2-24){ref-type="table"} lists the management site of all human encounters.

Among human exposures, 14,679 involved exposures to pharmaceutical agents, while 10,176 involved exposure to non-pharmaceuticals. Because an encounter could include both a pharmaceutical agent and non-pharmaceutical agent, this total is greater than the total number of encounters. However, 88.5% (n = 18,327) of all human exposures were exposed to only a single substance. Among these single substance exposures, the reason for exposure was intentional in 19.3% (n = 3,527) of pharmaceutical-only cases compared to 3.5% (n = 641) of non-pharmaceutical single substance exposures.

When medical outcomes were analyzed, 32% (n = 6,582) of human exposures had no effect, 19% (n = 3,911) had minor effect, 8% (n = 1,623) had moderate effect, and 2% (n = 348) major effects. Moderate and major effects were more common in those over 20 years of age and in those with intentional encounters. More serious outcomes were related to single-substance pharmaceutical exposures, accounting for 66.7% (n = 10) of the fatalities. [Table 10](#t10-kjm-11-2-24){ref-type="table"} lists all medical outcomes by age and [Table 11](#t11-kjm-11-2-24){ref-type="table"} lists them by reason for exposure.

Use of decontamination and specific therapies, including antidotal therapy, is detailed in [Tables 12a](#t12a-kjm-11-2-24){ref-type="table"} and [12b](#t12b-kjm-11-2-24){ref-type="table"}.

There were 15 deaths in 2016 reported to the PCC. Fourteen of the deaths involved patients 20 years of age or older. Fourteen of the death cases involved intentional exposures. [Table 13](#t13-kjm-11-2-24){ref-type="table"} details the 15 reported deaths.

[Table 14](#t14-kjm-11-2-24){ref-type="table"} compares key statistics from 2015 to 2016. Number of exposures, calls from healthcare facilities, moderate or major outcomes and deaths increased from 2015.

Discussion
==========

The University of Kansas Health System Poison Control Center has been in operation for 35 years and serves the state of Kansas 24 hours a day, 365 days a year. Receiving over 26,000 calls per year, the PCC is an integral part of the emergency medical response, public health and health care facilities in Kansas. Childhood poisonings, both unintentional and intentional, are a major focus, with calls for patients under 19 years of age accounting for approximately 2/3 of all exposures.

The PCC statistics are similar to those seen nationally.[@b1-kjm-11-2-24] In 2016, 2,710,042 encounters were logged by poison control centers nationwide, including 2,159,032 human exposures. Total encounters showed a 2.9% decline from 2015, but healthcare facility (HCF) human exposure cases increased by 3.6% from 2015. More serious outcomes (moderate, major or death) also increased. Nationwide, the five substance classes most frequently involved in adult exposures were analgesics, sedative/hypnotics/antipsychotics, antidepressants, cardiovascular drugs, and cleaning substances, while the top five most common exposures in children age 5 years or less were cosmetics/personal care products, household cleaning substances, analgesics, foreign bodies/toys/miscellaneous, and topical preparations. There were 1,415 exposure related fatalities reported nationwide in 2016.

The ongoing importance of the PCC is reflected in current trends that have seen rates of poisonings and overdoses increase at an alarming rate. The PCC saw an increase in number of calls from healthcare facilities, cases with moderate or major medical outcomes and deaths in 2016 compared to 2015. In an August 2017 report, the National Center for Health Statistic noted that the age-adjusted drug-poisoning death rate increased from 6.1 per 100,000 in 1999 to 16.3 per 100,000 in 2015, totaling over 50,000 deaths in 2015.[@b3-kjm-11-2-24] Teenage (age 15 -- 19) overdose deaths are increasing as well.[@b4-kjm-11-2-24] The ongoing "opioid epidemic" is a major driver in the rise of poisoning deaths.[@b3-kjm-11-2-24]

Reporting exposures to the PCC is voluntary and the PCC is not contacted for all poisonings in the state of Kansas. Furthermore, in a majority of cases there is no objective confirmation of exposure. These limitations should be noted when interpreting PCC data.

Conclusion
==========

The results of the 2016 University of Kansas Health System Poison Control annual report demonstrated that the center receives calls from the entire state of Kansas, totaling over 20,000 human exposures per year. While pediatric exposures remain the most common, there is an increasing number of calls from healthcare facilities and for cases with serious outcomes. The experience of the PCC is similar to national data. This report supports the continued value of the PCC to both public and acute health care in the state of Kansas.

We would like to thank Poison Control Center Staff: Tama Sawyer, PharmD, Anne Marie Banks, Amber Ashworth, Mike McKinney, Kathy White, Anita Farris, Mark Stallbaumer, and Bobbie Jean Wainscott.
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###### 

Encounter type.

                                     Number       \%
  ---------------------------------- ------------ ------------
  **Exposure**                                    
  Human Exposure                     20,713       94.32
  Animal Exposure                    112          0.51
  **Subtotal**                       **20,825**   **94.83**
  **Non-Exposure Confirmed Cases**                
  Human Non-Exposure                 87           0.39
  **Subtotal**                       **87**       **0.39**
  **Information Call**                            
  Drug information                   308          1.40
  Drug identification                189          0.86
  Environmental information          123          0.56
  Medical information                30           0.14
  Occupational information           1            0.00
  Poison information                 110          0.50
  Prevention / Safety / Education    30           0.14
  Teratogenicity information         1            0.00
  Other information                  49           0.22
  Substance Abuse                    6            0.03
  Administrative                     16           0.07
  Caller Referred                    190          0.86
  **Subtotal**                       **1,053**    **4.78**
  **Total**                          **21,965**   **100.00**

###### 

Distribution of human exposures by age and gender.

                                                      Male         Female      Unknown gender   Total       Cumulative Total                                                     
  --------------------------------------------------- ------------ ----------- ---------------- ----------- ------------------ ---------- ------------ ------------ ------------ ------------
  \< 1 year                                           619          52.32       526              47.73       1                  0.09       1,183        5.71         1,183        5.71
  1 year                                              1,971        53.26       1,626            46.50       2                  0.06       3,701        17.87        4,884        23.58
  2 years                                             1,773        52.39       1,579            46.30       1                  0.03       3,384        16.34        8,268        39.92
  3 years                                             852          55.32       681              45.49       3                  0.20       1,540        7.43         9,808        47.35
  4 years                                             400          58.48       320              44.02       2                  0.28       684          3.30         10,492       50.65
  5 years                                             245          56.71       204              47.11       0                  0.00       432          2.09         10,924       52.74
  Unknown ≤ 5 years                                   2            33.33       0                0.00        0                  0.00       6            0.03         10,930       52.77
  Child 6--12 years                                   768          61.89       470              39.83       1                  0.08       1,241        5.99         12,171       58.76
  Teen 13--19 years                                   620          35.98       990              62.15       2                  0.13       1,723        8.32         13,894       67.08
  Unknown Child                                       5            55.56       7                46.67       0                  0.00       9            0.04         13,903       67.12
  **Subtotal**                                        **7,255**    **52.18**   **6,403**        **47.58**   **12**             **0.09**   **13,903**   **67.12**    **13,903**   **67.12**
  20--29 years                                        841          47.30       924              52.77       1                  0.06       1,778        8.58         15,681       75.71
  30--39 years                                        577          41.72       747              56.12       2                  0.15       1,383        6.68         17,064       82.38
  40--49 years                                        447          42.53       558              56.94       3                  0.31       1,051        5.07         18,115       87.46
  50--59 years                                        364          40.40       565              57.77       0                  0.00       901          4.35         19,016       91.81
  60--69 years                                        292          39.25       411              57.97       1                  0.14       744          3.59         19,760       95.40
  70--79 years                                        166          37.22       260              59.50       1                  0.23       446          2.15         20,206       97.55
  80--89 years                                        81           33.20       150              64.94       1                  0.43       244          1.18         20,450       98.73
  ≥ 90 years                                          12           32.43       40               67.80       0                  0.00       37           0.18         20,487       98.91
  Unknown adult                                       47           36.43       107              66.88       1                  0.63       129          0.62         20,616       99.53
  **Subtotal**                                        **2,827**    **42.11**   **3,762**        **56.69**   **10**             **0.15**   **6,713**    **32.41**    **20,616**   **99.53**
  Total[\*](#tfn1-kjm-11-2-24){ref-type="table-fn"}   **10,096**   **48.74**   **10,174**       **50.59**   **26**             **0.13**   **20,713**   **100.00**   **20,713**   **100.00**

Total includes 97 unknown age cases.

###### 

Origin of call and site exposure for human exposure cases.

  Site                        Origin of Call   Site of Exposure            
  --------------------------- ---------------- ------------------ -------- -------
  Residence                                                                
   Own                        14,583           70.41              18,708   90.32
   Other                      381              1.84               768      3.71
  Workplace                   324              1.56               395      1.91
  Health care facility        4,500            21.73              71       0.34
  School                      54               0.26               242      1.17
  Restaurant / Food service   8                0.04               30       0.14
  Public area                 63               0.30               181      0.87
  Other                       775              3.74               164      0.79
  Unknown                     25               0.12               154      0.74

###### 

Route of human exposures.

                                Human exposures                
  ----------------------------- ----------------- ------------ --------------------------------------------------------
  Ingestion                     17,882            82.44        86.33
  Dermal                        1,312             6.05         6.33
  Inhalation/nasal              1,095             5.05         5.29
  Ocular                        855               3.94         4.13
  Bite/sting                    215               0.99         1.04
  Unknown                       157               0.72         0.76
  Parenteral                    115               0.53         0.56
  Other                         25                0.12         0.12
  Otic                          17                0.08         0.08
  Rectal                        8                 0.04         0.04
  Aspiration (with ingestion)   5                 0.02         0.02
  Vaginal                       5                 0.02         0.02
  **Total Number of Routes**    **21,691**        **100.00**   **104.72**[\*](#tfn2-kjm-11-2-24){ref-type="table-fn"}

Some cases may have multiple routes of exposure documented.

###### 

Substance categories most frequently involved in exposures for age ≤ 5 years old.

  Substance category                          All Substance   \%      Single substance exposures   \%
  ------------------------------------------- --------------- ------- ---------------------------- -------
  Cosmetics/Personal Care Products            1,362           11.89   1,333                        12.62
  Cleaning Substances (Household)             1,301           11.36   1,259                        11.92
  Analgesics                                  1,073           9.37    966                          9.14
  Foreign Bodies/Toys/Miscellaneous           610             5.32    589                          5.57
  Antihistamines                              590             5.15    537                          5.08
  Topical Preparations                        577             5.04    572                          5.41
  Vitamins                                    510             4.45    466                          4.41
  Dietary Supplements/ Herbals/ Homeopathic   430             3.75    401                          3.80
  Pesticides                                  418             3.65    408                          3.86
  Plants                                      282             2.46    260                          2.46
  Gastrointestinal Preparations               276             2.41    246                          2.33
  Cold and Cough Preparations                 250             2.18    228                          2.16
  Antimicrobials                              241             2.10    213                          2.02
  Hormones and Hormone Antagonists            227             1.98    157                          1.49
  Cardiovascular Drugs                        213             1.86    131                          1.24

###### 

Substance categories most frequently involved in exposures of adults (\> 20 years old).

  Substance category                  All substances   \%      Single substance exposures   \%
  ----------------------------------- ---------------- ------- ---------------------------- ------
  Sedative/Hypnotics/Antipsychotics   1,130            11.65   319                          6.14
  Analgesics                          1,103            11.37   508                          9.77
  Antidepressants                     786              8.10    248                          4.77
  Cardiovascular Drugs                654              6.74    223                          4.29
  Pesticides                          434              4.47    378                          7.27
  Cleaning Substances (Household)     405              4.18    314                          6.04
  Alcohols                            403              4.15    55                           1.06
  Anticonvulsants                     378              3.90    111                          2.14
  Antihistamines                      333              3.43    151                          2.91
  Hormones and Hormone Antagonists    272              2.80    135                          2.60
  Stimulants and Street Drugs         267              2.75    116                          2.23
  Chemicals                           233              2.40    205                          3.94
  Cosmetics/Personal Care Products    210              2.16    188                          3.62
  Cold and Cough Preparations         197              2.03    101                          1.94
  Muscle Relaxants                    190              1.96    67                           1.29

###### 

Top five most frequent plant exposures.

  Botanical Name or Category                        N
  ------------------------------------------------- ----
  *Phytolacca americana (L.) (Pokeweed)*            48
  Plants: Unknown Toxic Types or Unknown if Toxic   46
  *Spathiphyllum species (Peace Lily)*              14
  *Philodendron (Species unspecified)*              16
  *Cherry (Species unspecified)*                    12

###### 

Reason for human exposure cases.

  Reason             N                                   \% Human exposures   
  ------------------ ----------------------------------- -------------------- -----------
  Unintentional                                                               
                     Unintentional - General             11,971               57.8
                     Unintentional - Therapeutic error   2,361                11.4
                     Unintentional - Misuse              1,226                5.9
                     Unintentional - Environmental       625                  3.0
                     Unintentional - Occupational        238                  1.1
                     Unintentional - Bite / sting        217                  1.0
                     Unintentional - Food poisoning      160                  0.8
                     Unintentional - Unknown             38                   0.2
                     **Subtotal**                        **16,836**           **81.3**
  Intentional                                                                 
                     Intentional - Suspected suicide     2,415                11.7
                     Intentional - Misuse                527                  2.5
                     Intentional - Abuse                 348                  1.7
                     Intentional - Unknown               87                   0.4
                     **Subtotal**                        **3,377**            **16.3**
  Adverse Reaction                                                            
                     Adverse reaction - Drug             286                  1.4
                     Adverse reaction - Other            44                   0.2
                     Adverse reaction - Food             29                   0.1
                     **Subtotal**                        **359**              **1.7**
  Unknown                                                                     
                     Unknown reason                      77                   0.4
                     **Subtotal**                        **77**               **0.4**
  Other                                                                       
                     Other - Malicious                   43                   0.2
                     Other - Contamination / Tampering   15                   0.1
                     Other - Withdrawal                  6                    0.0
                     **Subtotal**                        **64**               **0.3**
                     **Total**                           **20,713**           **100.0**

###### 

Management site of human exposures.

  Site of management                          N            \%
  ------------------------------------------- ------------ -----------
  Managed in healthcare facility                           
  Treated/evaluated and released              3,153        15.2
  Admitted to critical care unit              1,281        6.2
  Admitted to noncritical care unit           721          3.5
  Admitted to psychiatric facility            417          2.0
  Patient lost to follow-up / left AMA        175          0.8
  **Subtotal (managed in HCF)**               **5,747**    **27.8**
  Managed on site, non-health care facility   14,732       71.1
  Other                                       19           0.1
  Refused referral                            197          1.0
  Unknown                                     18           0.1
  **Total**                                   **20,713**   **100.0**

###### 

Medical outcome of human exposure cases by patient age.

                                    ≤ 5 yrs      6--12 yrs    13--19 yrs   ≥ 20 yrs     Unknown child   Unknown adult   Unknown age   Total                                                                                       
  --------------------------------- ------------ ------------ ------------ ------------ --------------- --------------- ------------- ------------ ------- ------------ --------- ------------ -------- ------------ ------------ ------------
  No effect                         4,515        41.31        386          31.10        426             24.72           1,244         18.89        0       0.00         9         6.98         2        2.1          6,582        31.78
  Minor effect                      1,268        11.60        245          19.74        560             32.50           1,805         27.41        1       11.11        27        20.93        5        5.2          3,911        18.88
  Moderate effect                   92           0.84         39           3.14         309             17.93           1,112         16.89        0       0.00         2         1.55         69       71.1         1,623        7.84
  Major effect                      10           0.09         4            0.32         66              3.83            268           4.07         0       0.00         0         0.00         0        0.0          348          1.68
  Death                             0            0.00         0            0.00         1               0.06            12            0.18         0       0.00         0         0.00         0        0.0          13           0.06
  No follow-up, nontoxic            435          3.98         31           2.50         10              0.58            39            0.59         0       0.00         2         1.55         1        1.0          518          2.50
  No follow-up, minimal toxicity    4,305        39.39        504          40.61        242             14.05           1,542         23.42        4       44.44        53        41.09        8        8.3          6,658        32.14
  No follow-up, potentially toxic   207          1.89         16           1.29         73              4.24            281           4.27         3       33.33        24        18.60        10       10.3         614          2.96
  Unrelated effect                  98           0.90         16           1.29         36              2.09            279           4.24         1       11.11        12        9.30         2        2.1          444          2.14
  Death, indirect report            0            0.00         0            0.00         0               0.00            2             0.03         0       0.00         0         0.00         0        0.0          2            0.01
  **Total**                         **10,930**   **100.00**   **1,241**    **100.00**   **1,723**       **100.00**      **6,584**     **100.00**   **9**   **100.00**   **129**   **100.00**   **97**   **100.00**   **20,713**   **100.00**

###### 

Medical outcome by reason for exposure in human exposures.

                                    Unintentional   Intentional   Other       Adverse reaction   Unknown   Total                                                                  
  --------------------------------- --------------- ------------- ----------- ------------------ --------- ------------ --------- ------------ -------- ------------ ------------ ------------
  Death                             0               0.00          13          0.38               0         0.00         0         0.00         0        0.00         13           0.06
  Death, indirect report            0               0.00          1           0.03               0         0.00         0         0.00         1        1.30         2            0.01
  Major effect                      53              0.31          273         8.08               0         0.00         9         2.51         13       16.88        348          1.68
  Minor effect                      2,746           16.31         1,012       29.97              19        29.69        121       33.70        13       16.88        3,911        18.88
  Moderate effect                   574             3.41          978         28.96              5         7.81         46        12.81        20       25.97        1,623        7.84
  No effect                         5,836           34.66         720         21.32              7         10.94        14        3.90         5        6.49         6,582        31.78
  No follow-up, nontoxic            512             3.04          4           0.12               1         1.56         1         0.28         0        0.00         518          2.50
  No follow-up, minimal toxicity    6,399           38.01         146         4.32               17        26.56        92        25.63        4        5.19         6,658        32.14
  No follow-up, potentially toxic   391             2.32          189         5.60               7         10.94        16        4.46         11       14.29        614          2.96
  Unrelated effect                  325             1.93          41          1.21               8         12.50        60        16.71        10       12.99        444          2.14
  **Total**                         **16,836**      **100.00**    **3,377**   **100.00**         **64**    **100.00**   **359**   **100.00**   **77**   **100.00**   **20,713**   **100.00**

###### 

Decontamination provided in human exposures by age.

  Decontamination            ≤ 5 yrs   6--12 yrs   13--19 yrs   ≥ 20 yrs   Unknown child   Unknown adult   Unknown age   Total
  -------------------------- --------- ----------- ------------ ---------- --------------- --------------- ------------- --------
  Cathartic                  2         3           40           46         0               0               0             91
  Charcoal, multiple doses   1         2           9            5          0               0               0             17
  Charcoal, single dose      87        14          176          202        0               0               0             479
  Dilute/irrigate/wash       8,317     796         445          2,649      7               58              3             12,275
  Food/snack                 1,516     142         83           369        0               3               1             2,114
  Fresh air                  67        35          37           403        3               26              3             574
  Lavage                     0         0           1            6          0               0               0             7
  Other emetic               57        6           4            39         0               1               0             107
  Whole bowel irrigation     0         0           1            8          0               0               0             9

###### 

Therapy provided in human exposures by age.

  Therapy                        ≤ 5 yrs   6--12 yrs   13--19 yrs   ≥ 20 yrs   Unknown child   Unknown adult   Unknown age   Total
  ------------------------------ --------- ----------- ------------ ---------- --------------- --------------- ------------- -------
  Alkalinization                 4         2           39           143        0               0               0             188
  Antiarrhythmic                 0         1           0            5          0               0               0             6
  Antibiotics                    27        10          19           185        0               2               0             243
  Anticonvulsants                0         0           2            5          0               0               0             7
  Antiemetics                    16        9           128          177        0               0               0             330
  Antihistamines                 19        8           21           86         0               0               1             135
  Antihypertensives              0         0           1            18         0               0               0             19
  Antivenin (fab fragment)       1         1           2            8          0               0               0             12
  Antivenin/antitoxin            0         1           4            10         0               0               0             15
  Atropine                       0         1           1            12         0               0               0             14
  Benzodiazepines                17        7           93           270        0               0               0             387
  Bronchodilators                2         5           2            48         0               2               69            128
  Calcium                        164       8           3            31         0               0               0             206
  CPR                            0         0           2            7          0               0               0             9
  Deferoxamine                   0         0           0            2          0               0               0             2
  Ethanol                        0         0           0            1          0               0               0             1
  Extracorp. procedure (other)   0         0           0            1          0               0               0             1
  Fab fragments                  0         0           0            8          0               0               0             8
  Fluids, IV                     57        23          490          1,313      0               1               1             1,885
  Flumazenil                     0         1           6            33         0               0               0             40
  Fomepizole                     4         0           2            15         0               0               0             21
  Glucagon                       1         0           4            25         0               0               0             30
  Glucose, \> 5%                 4         0           1            42         0               0               0             47
  Hemodialysis                   0         0           3            21         0               0               0             24
  Hydroxocobalamin               3         1           0            1          0               0               0             5
  Hyperbaric oxygen              0         0           0            2          0               0               0             2
  Insulin                        0         0           1            23         0               0               0             24
  Intubation                     3         3           27           153        0               0               0             186
  Methylene blue                 0         0           0            3          0               0               0             3
  NAC, IV                        1         0           63           105        0               0               0             169
  NAC, PO                        1         1           14           19         0               0               0             35
  Naloxone                       5         1           23           131        0               0               0             160
  Neuromuscular blocker          2         0           0            6          0               0               0             8
  Octreotide                     1         0           0            0          0               0               0             1
  Other                          55        16          99           357        2               3               0             532
  Oxygen                         9         8           56           379        0               0               69            521
  Physostigmine                  0         0           4            9          0               0               0             13
  Phytonadione                   0         0           1            12         0               0               0             13
  Sedation (other)               6         5           26           136        0               0               0             173
  Sodium thiosulfate             1         0           0            0          0               0               0             1
  Steroids                       8         2           7            77         0               1               69            164
  Vasopressors                   0         1           8            65         0               0               0             74
  Ventilator                     3         3           27           155        0               0               0             188

###### 

Details on deaths and exposure related fatalities.

  Age & Gender                            Substances                        Substance Rank   Cause Rank   Chronicity         Route   Reason
  --------------------------------------- --------------------------------- ---------------- ------------ ------------------ ------- --------
  **NON-PHARMACEUTICAL EXPOSURES**                                                                                                   
  **Fumes/Gases/Vapors**                                                                                                             
  17 year Male                            Carbon Monoxide                   1                1            Acute              Inhal   Int-S
  **Heavy Metals**                                                                                                                   
  68 year Female                          Copper                            1                1            Acute              Ingst   Int-S
  **PHARMACEUTICAL EXPOSURES**                                                                                                       
  **Analgesics**                                                                                                                     
  73 year Male                            Acetaminophen/Hydrocodone         1                1            Acute on Chronic   Ingst   Int-S
                                          Zolpidem                          2                2            Acute on Chronic   Ingst   
  **Antihistamines**                                                                                                                 
  38 year Female                          Diphenhydramine                   1                1            Acute              Ingst   Int-S
  **Cardiovascular Drugs**                                                                                                           
  21 year Female                          Labetalol                         1                1            Unknown            Ingst   Int-S
                                          Clonazepam                        2                2            Unknown            Ingst   
  45 year Female                          Propranolol                       1                1            Acute              Ingst   Int-S
                                          Valproic Acid                     2                2            Acute              Ingst   
                                          Olanzapine                        3                3            Acute              Ingst   
                                          Bupropion                         4                4            Acute              Ingst   
  46 year Male                            Amlodipine                        1                1            Acute on Chronic   Ingst   Int-S
                                          Lamotrigine                       2                2            Acute on Chronic   Ingst   
                                          Metformin                         3                3            Acute on Chronic   Ingst   
                                          Citalopram                        4                4            Acute on Chronic   Ingst   
                                          Fenobibrate                       5                5            Acute on Chronic   Ingst   
                                          Alpha Blocker                     6                6            Acute on Chronic   Ingst   
                                          Quetiapine                        7                7            Acute on Chronic   Ingst   
                                          Lisinopril                        8                8            Acute on Chronic   Ingst   
                                          Bupropion (Extended Release)      9                9            Acute on Chronic   Ingst   
                                          Ethanol                           10               10           Acute on Chronic   Ingst   
  46 year Female                          Propranolol                       1                1            Acute              Ingst   Int-S
                                          Trazodone                         2                2            Acute              Ingst   
                                          Paroxetine                        3                3            Acute              Ingst   
  60 year Male                            Carvedilol                        1                1            Acute on Chronic   Ingst   Int-S
                                          Amlodipine                        2                2            Acute on Chronic   Ingst   
                                          Hydrochlorothiazide/ Lisinopril   3                3            Acute on Chronic   Ingst   
                                          Clopidogrel                       4                4            Acute on Chronic   Ingst   
                                          Duloxetine                        5                5            Acute on Chronic   Ingst   
                                          Acetaminophen/ Hydrocodone        6                6            Acute on Chronic   Ingst   
                                          Dexlansoprazole                   7                7            Acute on Chronic   Ingst   
                                          Quetiapine                        8                8            Acute on Chronic   Ingst   
  73 year Female                          Metoprolol                        1                1            Acute on Chronic   Ingst   Int-S
                                          Duloxetine                        2                2            Acute on Chronic   Ingst   
                                          Trazodone                         3                3            Acute on Chronic   Ingst   
                                          Donepezil                         4                4            Acute on Chronic   Ingst   
                                          Baclofen                          5                5            Acute on Chronic   Ingst   
                                          Benztropine                       6                6            Acute on Chronic   Ingst   
                                          Lurasidone                        7                7            Acute on Chronic   Ingst   
                                          Alprazolam                        8                8            Acute on Chronic   Ingst   
                                          Zolpidem                          9                9            Acute on Chronic   Ingst   
                                          Meloxicam                         10               10           Acute on Chronic   Ingst   
                                          Salicylate                        11               11           Acute on Chronic   Ingst   
                                          Levothyroxine                     12               12           Acute on Chronic   Ingst   
                                          Omeprazole                        13               13           Acute on Chronic   Ingst   
                                          Vitamin D                         14               14           Acute on Chronic   Ingst   
  96 year Female                          Calcium Antagonist                1                1            Acute              Ingst   Unk
  **Cold and Cough Preparations**                                                                                                    
  30 year Male                            Dextromethorphan/ Guaifenesin     1                1            Acute              Ingst   Int-U
  **Electrolytes And Minerals**                                                                                                      
  63 year Female                          Iron                              1                1            Acute on Chronic   Ingst   Int-S
                                          Ibuprofen                         2                2            Acute on Chronic   Ingst   
                                          Levothyroxine                     3                3            Acute on Chronic   Ingst   
  **Sedative/Hypnotics/Antipsychotics**                                                                                              
  48 year Female                          Quetiapine                        1                1            Acute on Chronic   Ingst   Int-S
  **Stimulants and Street Drugs**                                                                                                    
  20 year Male                            Heroin                            1                1            Acute on Chronic   Par     Int-A
                                          Ethanol                           2                2            Acute on Chronic   Ingst   

Abbreviations: Inhal: Inhalation; Ingst: Ingestion; Par: Parenteral; Int-S: Intentional-Self; Int-U; Intentional-Unknown; Int-A: Intentional-Another; Unk: Unknown.

###### 

2015 to 2016 comparison of select statistics.

                                        2015     2016
  ------------------------------------- -------- --------
  **Total Cases**                       20,109   21,965
  **Calls from Health Care Facility**   4,267    4,514
  **Moderate or Major Outcomes**        1,688    1,971
  **Deaths**                            13       15
